Cargando…
Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections
Lower respiratory infection caused by human pathogens such as influenza and respiratory syncytial virus (RSV) is a significant healthcare burden that must be addressed. The preferred options to achieve this goal are usually to develop vaccines for prophylaxis and to develop antiviral small molecules...
Autor principal: | Nyanguile, Origène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598224/ https://www.ncbi.nlm.nih.gov/pubmed/31293570 http://dx.doi.org/10.3389/fimmu.2019.01366 |
Ejemplares similares
-
Targeting the Respiratory Syncytial Virus N(0)-P Complex with Constrained α-Helical Peptides in Cells and Mice
por: Galloux, Marie, et al.
Publicado: (2020) -
A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading
por: Gaillard, Vanessa, et al.
Publicado: (2017) -
Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion
por: Lei, Vivian, et al.
Publicado: (2020) -
The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma—Food for Thought?
por: Lynch, Jason P., et al.
Publicado: (2017) -
Lipopolysaccharide-induced interferon response networks at birth are predictive of severe viral lower respiratory infections in the first year of life
por: Read, James F., et al.
Publicado: (2022)